Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis (video)

GRACEcast Cancer 101 Audio
17/05/2013 11 min
Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis (video)

Listen "Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis (video)"

Descargar episodio Ver en sitio original

Episode Synopsis

Dr. Johannes Kratz, surgeon at Massachusetts General Hospital, reviews early efforts in molecularly-defined staging of patients with early stage non-small cell lung cancer (NSCLC).

More episodes of the podcast GRACEcast Cancer 101 Audio

Should Small Cell Lung Cancer Patients Who Respond to Chemo Receive Consolidation Radiotherapy? 31/07/2014
Management of Rare Kidney Tumors 29/07/2014
Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation? 27/07/2014
NanoString Treatment for Kidney Cancer 24/07/2014
Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer? 22/07/2014
How is the Heng Criteria Applied to Kidney Cancer Patients? 20/07/2014
Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment? 17/07/2014
What is PD1 and PDL1 in Kidney Cancer? 15/07/2014
Zykadia for ALK Positive Lung Cancer: New Drug, New Hope 13/07/2014
No Clear Answer for Non-Clear Cell Kidney Cancer 10/07/2014
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA